GSK may get EU green light for new biotech asthma drug this week
September 23, 2015 at 11:02 AM EDT
LONDON, Sept 23 (Reuters) - GlaxoSmithKline may get a green light from European regulators as early as this week for a new biotech medicine to treat severe asthma, boosting prospects for its struggling respiratory business.
